What is Biotrillion?
BioTrillion operates at the intersection of mobile technology and predictive medicine. Its core innovation, the BioEngine4D platform, transforms standard smartphone hardware into sophisticated health monitoring tools. By democratizing access to clinical-grade insights, the company addresses critical gaps in early disease detection and personalized wellness. The platform serves a dual-market strategy, providing actionable intelligence to individual consumers while simultaneously offering robust data analytics for pharmaceutical research and drug development pipelines. This dual-pronged approach allows BioTrillion to scale efficiently across both B2B and B2C verticals, establishing a defensible moat in the competitive digital health landscape.
How much funding has Biotrillion raised?
Biotrillion has raised a total of $23K across 1 funding round:
Debt
$23K
Debt (2021): $23K with participation from PPP
Key Investors in Biotrillion
PPP
Public-Private Partnership
What's next for Biotrillion?
With this recent infusion of capital, BioTrillion is well-positioned to accelerate its product roadmap and expand its market footprint. The strategic focus will likely center on enhancing the predictive accuracy of the BioEngine4D platform and deepening partnerships within the life sciences industry. As the company transitions through its current growth phase, the emphasis will remain on scaling its AI infrastructure to support a larger user base and refining its data-driven drug development capabilities. Investors are closely watching how the firm navigates the regulatory complexities of digital health while maintaining its commitment to accessible, high-fidelity health monitoring solutions.
See full Biotrillion company page
